Semaglutide has quickly become a revolutionary medication in the management of type 2 diabetes, obesity, and cardiovascular health. Initially developed as a treatment for diabetes, semaglutide belongs to the class of drugs known as GLP-1 receptor agonists. These medications mimic the effects of a natural hormone called GLP-1 (glucagon-like peptide-1) https://devinkptyc.smblogsites.com/30992439/semaglutide-revolutionizing-diabetes-obesity-and-cardiovascular-health